{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:40:16Z","timestamp":1792518016158,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"vor","delay-in-days":75,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Ningbo Natural Science Foundation\uff0cChina","award":["2024J392"],"award-info":[{"award-number":["2024J392"]}]},{"name":"Health Industry Science and Technology Program of Zhejiang Province,China.","award":["2025HY0997"],"award-info":[{"award-number":["2025HY0997"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-026-02274-5","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T11:15:02Z","timestamp":1786014902000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Construction of a liver hepatocellular carcinoma risk model based on fumarate metabolism-associated genes to predict prognosis and immunological landscape"],"prefix":"10.1007","volume":"26","author":[{"given":"Shuhuai","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujie","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanxia","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,6]]},"reference":[{"key":"2274_CR1","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/978-3-030-65768-0_9","volume":"1311","author":"J Salazar","year":"2021","unstructured":"Salazar J, Le A. The Heterogeneity of Liver Cancer Metabolism. Adv Exp Med Biol. 2021;1311:127\u201336.","journal-title":"Adv Exp Med Biol"},{"issue":"4","key":"2274_CR2","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.ccell.2024.03.004","volume":"42","author":"H Yang","year":"2024","unstructured":"Yang H, Cheng J, Zhuang H, Xu H, Wang Y, Zhang T, et al. Pharmacogenomic profiling of intra-tumor heterogeneity using a large organoid biobank of liver cancer. Cancer Cell. 2024;42(4):535\u2013e518.","journal-title":"Cancer Cell"},{"key":"2274_CR3","unstructured":"Pol S. [Hepatocellular carcinoma (HCC)]. Med Trop Sante Int. 2024;4(4): e614."},{"issue":"11","key":"2274_CR4","doi-asserted-by":"publisher","first-page":"113446","DOI":"10.1016\/j.celrep.2023.113446","volume":"42","author":"AJ Craig","year":"2023","unstructured":"Craig AJ, Silveira MAD, Ma L, Revsine M, Wang L, Heinrich S, et al. Genome-wide profiling of transcription factor activity in primary liver cancer using single-cell ATAC sequencing. Cell Rep. 2023;42(11):113446.","journal-title":"Cell Rep"},{"issue":"6","key":"2274_CR5","first-page":"e85985","volume":"17","author":"S Iqbal","year":"2025","unstructured":"Iqbal S, Qureshi Z, Mudasir HM, Khan A, Sohail A, Ahmad J, et al. Prevalence and Risk Factors of Hepatocellular Carcinoma in Patients Co-infected With Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV): A Cross-Sectional Retrospective Study. Cureus. 2025;17(6):e85985.","journal-title":"Cureus"},{"issue":"1","key":"2274_CR6","doi-asserted-by":"publisher","first-page":"2455539","DOI":"10.1080\/07853890.2025.2455539","volume":"57","author":"J Wang","year":"2025","unstructured":"Wang J, Qiu K, Zhou S, Gan Y, Jiang K, Wang D, et al. Risk factors for hepatocellular carcinoma: an umbrella review of systematic review and meta-analysis. Ann Med. 2025;57(1):2455539.","journal-title":"Ann Med"},{"issue":"10360","key":"2274_CR7","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","volume":"400","author":"A Vogel","year":"2022","unstructured":"Vogel A, Meyer T, Sapisochin G, Salem R, Saborowski A. Hepatocellular carcinoma. Lancet. 2022;400(10360):1345\u201362.","journal-title":"Lancet"},{"issue":"2","key":"2274_CR8","doi-asserted-by":"publisher","first-page":"e100186","DOI":"10.1136\/egastro-2025-100186","volume":"3","author":"B Bueloni","year":"2025","unstructured":"Bueloni B, Garcia Fernandez de Barrena M, Avila MA, Bayo J, Mazzolini G. Epigenetic mechanisms involved in hepatocellular carcinoma development and progression. eGastroenterology. 2025;3(2):e100186.","journal-title":"eGastroenterology"},{"issue":"10","key":"2274_CR9","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/s41575-022-00620-y","volume":"19","author":"P Johnson","year":"2022","unstructured":"Johnson P, Zhou Q, Dao DY, Lo YMD. Circulating biomarkers in the diagnosis and management of hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 2022;19(10):670\u201381.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"2274_CR10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s44276-025-00126-5","volume":"3","author":"C Mysko","year":"2025","unstructured":"Mysko C, Landi S, Purssell H, Allen AJ, Prince M, Lindsay G, et al. Health inequalities in hepatocellular carcinoma surveillance, diagnosis, treatment, and survival in the United Kingdom: a scoping review. BJC Rep. 2025;3(1):13.","journal-title":"BJC Rep"},{"issue":"19","key":"2274_CR11","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1097\/CM9.0000000000001952","volume":"135","author":"J Sun","year":"2022","unstructured":"Sun J, Liu C, Shi J, Wang N, Jiang D, Mao F, et al. A novel chemotherapy strategy for advanced hepatocellular carcinoma: a multicenter retrospective study. Chin Med J (Engl). 2022;135(19):2338\u201343.","journal-title":"Chin Med J (Engl)"},{"issue":"1","key":"2274_CR12","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41392-025-02333-5","volume":"10","author":"C Zhao","year":"2025","unstructured":"Zhao C, Zhang Y, Wang G, Zheng J, Chen W, Lu Z, et al. Finotonlimab (PD-1 inhibitor) plus bevacizumab (bevacizumab biosimilar) as first-tier therapy for late-stage hepatocellular carcinoma: a randomized phase 2\/3 trial. Signal Transduct Target Ther. 2025;10(1):249.","journal-title":"Signal Transduct Target Ther"},{"issue":"10","key":"2274_CR13","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1001\/jamaoncol.2025.2470","volume":"11","author":"C Celsa","year":"2025","unstructured":"Celsa C, Di Maria G, Lombardi P, D\u2019Alessio A, Fulgenzi CAM, Brunetti L, et al. Integrating Quality of Life and Survival in Systemic Therapy for Advanced Hepatocellular Carcinoma: A Network Meta-Analysis. JAMA Oncol. 2025;11(10):1160\u20138.","journal-title":"JAMA Oncol"},{"key":"2274_CR14","doi-asserted-by":"crossref","unstructured":"Esteban-Amo MJ, Jim\u00e9nez-Cuadrado P, Serrano-Lorenzo P, de la Fuente M, Simarro M. Succinate Dehydrogenase and Human Disease: Novel Insights into a Well-Known Enzyme. Biomedicines. 2024;12(9):2050.","DOI":"10.3390\/biomedicines12092050"},{"key":"2274_CR15","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.freeradbiomed.2019.12.037","volume":"148","author":"AM Manuel","year":"2020","unstructured":"Manuel AM, Walla MD, Dorn MT, Tanis RM, Piroli GG, Frizzell N. Fumarate and oxidative stress synergize to promote stability of C\/EBP homologous protein in the adipocyte. Free Radic Biol Med. 2020;148:70\u201382.","journal-title":"Free Radic Biol Med"},{"issue":"12","key":"2274_CR16","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1038\/s41418-024-01402-6","volume":"31","author":"L Lanzetti","year":"2024","unstructured":"Lanzetti L. Oncometabolites at the crossroads of genetic, epigenetic and ecological alterations in cancer. Cell Death Differ. 2024;31(12):1582\u201394.","journal-title":"Cell Death Differ"},{"issue":"6","key":"2274_CR17","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.tcb.2023.10.005","volume":"34","author":"CG Peace","year":"2024","unstructured":"Peace CG, O\u2019Carroll SM, O\u2019Neill LAJ. Fumarate hydratase as a metabolic regulator of immunity. Trends Cell Biol. 2024;34(6):442\u201350.","journal-title":"Trends Cell Biol"},{"issue":"10","key":"2274_CR18","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1038\/s41416-023-02412-w","volume":"129","author":"L Valcarcel-Jimenez","year":"2023","unstructured":"Valcarcel-Jimenez L, Frezza C. Fumarate hydratase (FH) and cancer: a paradigm of oncometabolism. Br J Cancer. 2023;129(10):1546\u201357.","journal-title":"Br J Cancer"},{"issue":"11","key":"2274_CR19","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.tem.2025.03.008","volume":"36","author":"J Cheng","year":"2025","unstructured":"Cheng J, Xiao Y, Jiang P. Fumarate integrates metabolism and immunity in diseases. Trends Endocrinol Metab. 2025;36(11):985\u201399.","journal-title":"Trends Endocrinol Metab"},{"issue":"7","key":"2274_CR20","doi-asserted-by":"publisher","first-page":"3991","DOI":"10.21037\/tcr-2025-29","volume":"14","author":"Z Feng","year":"2025","unstructured":"Feng Z, Yang Y, Li J, Zuo L, Duan M, Xu B, et al. A novel fumaric acid metabolism-related prognostic signature associated with prognosis and immune infiltration landscape in laryngeal squamous cell carcinoma. Transl Cancer Res. 2025;14(7):3991\u20134008.","journal-title":"Transl Cancer Res"},{"key":"2274_CR21","doi-asserted-by":"publisher","first-page":"155909","DOI":"10.1016\/j.metabol.2024.155909","volume":"155","author":"X Pan","year":"2024","unstructured":"Pan X, Hu S, Xu Y, Gopoju R, Zhu Y, Cassim Bawa FN, et al. Kr\u00fcppel-like factor 10 protects against metabolic dysfunction-associated steatohepatitis by regulating HNF4\u03b1-mediated metabolic pathways. Metabolism. 2024;155:155909.","journal-title":"Metabolism"},{"issue":"1","key":"2274_CR22","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s10577-025-09780-4","volume":"33","author":"Z Puka\u0142o","year":"2025","unstructured":"Puka\u0142o Z, Medina-Pritchard B, Abad MA, Jeyaprakash AA. Preserving centromere identity: right amounts of CENP-A at the right place and time. Chromosome Res. 2025;33(1):21.","journal-title":"Chromosome Res"},{"issue":"16","key":"2274_CR23","doi-asserted-by":"publisher","first-page":"5218","DOI":"10.7150\/ijbs.85656","volume":"19","author":"J Liao","year":"2023","unstructured":"Liao J, Chen Z, Chang R, Yuan T, Li G, Zhu C, et al. CENPA functions as a transcriptional regulator to promote hepatocellular carcinoma progression via cooperating with YY1. Int J Biol Sci. 2023;19(16):5218\u201332.","journal-title":"Int J Biol Sci"},{"key":"2274_CR24","doi-asserted-by":"publisher","first-page":"3040839","DOI":"10.1155\/2020\/3040839","volume":"2020","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Yang L, Shi J, Lu Y, Chen X, Yang Z. The Oncogenic Role of CENPA in Hepatocellular Carcinoma Development: Evidence from Bioinformatic Analysis. Biomed Res Int. 2020;2020:3040839.","journal-title":"Biomed Res Int"},{"issue":"1","key":"2274_CR25","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/s41525-025-00511-6","volume":"10","author":"A Shorbaji","year":"2025","unstructured":"Shorbaji A, Pushparaj PN, Al-Ghafari AB, Mira LS, Basabrain MA, Naseer MI, et al. A narrative review of research advancements in pharmacogenetics of cardiovascular disease and impact on clinical implications. NPJ Genom Med. 2025;10(1):54.","journal-title":"NPJ Genom Med"},{"key":"2274_CR26","doi-asserted-by":"crossref","unstructured":"Yin X, Cicali B, Rodriguez-Vera L, Lukacova V, Cristofoletti R, Schmidt S. Applying Physiologically Based Pharmacokinetic Modeling to Interpret Carbamazepine\u2019s Nonlinear Pharmacokinetics and Its Induction Potential on Cytochrome P450 3A4 and Cytochrome P450 2C9 Enzymes. Pharmaceutics. 2024;16(6):737.","DOI":"10.3390\/pharmaceutics16060737"},{"key":"2274_CR27","doi-asserted-by":"publisher","first-page":"1639646","DOI":"10.3389\/fphar.2025.1639646","volume":"16","author":"H Ali","year":"2025","unstructured":"Ali H, Hanna MM, Alziny N, Mahmoud S, Borham A, Mustafa A, et al. The impact of the exposome on cytochrome P450-mediated drug metabolism. Front Pharmacol. 2025;16:1639646.","journal-title":"Front Pharmacol"},{"key":"2274_CR28","doi-asserted-by":"publisher","first-page":"154243","DOI":"10.1016\/j.tox.2025.154243","volume":"518","author":"S Zhan","year":"2025","unstructured":"Zhan S, Li C, Zeng K, Ran Y, Liu C, Zhang Y, et al. Phthalate exposure and hepatocellular carcinoma: Unraveling mechanisms through network toxicology. Toxicology. 2025;518:154243.","journal-title":"Toxicology"},{"issue":"8092","key":"2274_CR29","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41586-025-09574-y","volume":"648","author":"H Li","year":"2025","unstructured":"Li H, Lan L, Chen H, Zaw Thin M, Ps H, Nelson JK, et al. SPP1 is required for maintaining mesenchymal cell fate in pancreatic cancer. Nature. 2025;648(8092):203\u20139.","journal-title":"Nature"},{"issue":"1","key":"2274_CR30","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s10142-025-01664-4","volume":"25","author":"Z Wang","year":"2025","unstructured":"Wang Z, Wang C. SPP1 promotes malignant characteristics and drug resistance in hepatocellular carcinoma by activating fatty acid metabolic pathway. Funct Integr Genomics. 2025;25(1):151.","journal-title":"Funct Integr Genomics"},{"key":"2274_CR31","doi-asserted-by":"crossref","unstructured":"Tang J, Li Y, Xia S, Li J, Yang Q, Ding K et al. Sequestosome 1\/p62: A multitasker in the regulation of malignant tumor aggression (Review). Int J Oncol. 2021;59(4):77.","DOI":"10.3892\/ijo.2021.5257"},{"issue":"12","key":"2274_CR32","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.4254\/wjh.v13.i12.2137","volume":"13","author":"T Yosef","year":"2021","unstructured":"Yosef T, Ibrahim WA, Matboli M, Swilam AA, El-Nakeep S. New stem cell autophagy surrogate diagnostic biomarkers in early-stage hepatocellular carcinoma in Egypt: A pilot study. World J Hepatol. 2021;13(12):2137\u201349.","journal-title":"World J Hepatol"},{"issue":"1","key":"2274_CR33","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/s41419-025-07544-w","volume":"16","author":"Y Pan","year":"2025","unstructured":"Pan Y, Zhou H, Sun Z, Zhu Y, Zhang Z, Han J, et al. Regulatory T cells in solid tumor immunotherapy: effect, mechanism and clinical application. Cell Death Dis. 2025;16(1):277.","journal-title":"Cell Death Dis"},{"issue":"1","key":"2274_CR34","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.4110\/in.2025.25.e13","volume":"25","author":"J Kim","year":"2025","unstructured":"Kim J, Li J, Wei J, Lim SA. Regulatory T Cell Metabolism: A Promising Therapeutic Target for Cancer Treatment? Immune Netw. 2025;25(1):e13.","journal-title":"Immune Netw"},{"issue":"1","key":"2274_CR35","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1038\/s41598-024-81726-y","volume":"15","author":"X Zhao","year":"2025","unstructured":"Zhao X, Yang L, Pan J, Zeng Z, Zhang T, Yang Y, et al. CXCL8 modulates M0 macrophage proliferation and polarization to influence tumor progression in cervical cancer. Sci Rep. 2025;15(1):790.","journal-title":"Sci Rep"},{"issue":"11","key":"2274_CR36","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.7150\/ijms.98007","volume":"21","author":"C Pan","year":"2024","unstructured":"Pan C, Dai J, Wei Y, Yang L, Ding Z, Wang X, et al. Matrix Metalloproteinase 11 Promotes Migration and Invasion of Colorectal Cancer by Elevating Slug Protein. Int J Med Sci. 2024;21(11):2170\u201388.","journal-title":"Int J Med Sci"},{"issue":"1","key":"2274_CR37","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1186\/s12967-025-06291-y","volume":"23","author":"Y Lin","year":"2025","unstructured":"Lin Y, Song Y, Zhang Y, Li X, Kan L, Han S. New insights on anti-tumor immunity of CD8(+) T cells: cancer stem cells, tumor immune microenvironment and immunotherapy. J Transl Med. 2025;23(1):341.","journal-title":"J Transl Med"},{"issue":"1","key":"2274_CR38","doi-asserted-by":"publisher","first-page":"30518","DOI":"10.1038\/s41598-025-14720-7","volume":"15","author":"J Mai","year":"2025","unstructured":"Mai J, Yang L, Chen Y, Zeng X, Xie H, Liu X. Prediction of CD8(+) T cell infiltration in the tumor microenvironment of HGSOC patients. Sci Rep. 2025;15(1):30518.","journal-title":"Sci Rep"},{"key":"2274_CR39","doi-asserted-by":"publisher","first-page":"650673","DOI":"10.3389\/fonc.2021.650673","volume":"11","author":"Q Jiang","year":"2021","unstructured":"Jiang Q, Sun J, Chen H, Ding C, Tang Z, Ruan Y, et al. Establishment of an Immune Cell Infiltration Score to Help Predict the Prognosis and Chemotherapy Responsiveness of Gastric Cancer Patients. Front Oncol. 2021;11:650673.","journal-title":"Front Oncol"},{"issue":"1","key":"2274_CR40","doi-asserted-by":"publisher","first-page":"6561","DOI":"10.1038\/s41467-025-61713-1","volume":"16","author":"D Cai","year":"2025","unstructured":"Cai D, Qi H, Yang Q, Li H, Li C, Hu C, et al. Personalized risk stratification in colorectal cancer via PIANOS system. Nat Commun. 2025;16(1):6561.","journal-title":"Nat Commun"},{"issue":"1","key":"2274_CR41","doi-asserted-by":"publisher","first-page":"24426","DOI":"10.1038\/s41598-024-75270-y","volume":"14","author":"Z Wang","year":"2024","unstructured":"Wang Z, Sun Z, Lv H, Wu W, Li H, Jiang T. Machine learning-based model for CD4(+) conventional T cell genes to predict survival and immune responses in colorectal cancer. Sci Rep. 2024;14(1):24426.","journal-title":"Sci Rep"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-026-02274-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02274-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02274-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:02:07Z","timestamp":1792515727000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-026-02274-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,6]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2274"],"URL":"https:\/\/doi.org\/10.1007\/s10238-026-02274-5","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,6]]},"assertion":[{"value":"22 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"360"}}